| 効果 | なし |
| 試験方法 | コホート法 |
| 試験期間 | 6+ Months |
| 被験者数 | 25 |
| 性別 | 男女 |
| 年齢 | 45-64 |
| 体型 | 肥満 |
この研究の注釈：
Supplementation of 1,000µg chromium (as picolinate) alongside sulfonylurea therapy for 10 months in type II diabetic persons noted that, relative to a sulfonylurea/placebo pairing, that chromium resulted in an additional decrease in glucose and free fatty acids in serum without any other significant alterations.
Supplementation of 1,000µg chromium (as picolinate) alongside sulfonylurea therapy for 10 months in type II diabetic persons noted that, relative to a sulfonylurea/placebo pairing, that chromium resulted in an additional decrease in glucose and free fatty acids in serum without any other significant alterations.
There appeared to be an anti-obese effect of chromium, as the 0.9kg weight gain with sulfonylurea therapy was mitigated with chromium coingestion.
Effects Of Short-term Chromium Supplementation On Insulin Sensitivity And Body Composition In Overweight Children: Randomized, Double-blind, Placebo-controlled Study
| 効果 | なし |
| 試験方法 | 二重盲検法 |
| 試験期間 | 1-6 ヶ月 |
| 被験者数 | 25 |
| 性別 | 男女 |
| 年齢 | 7-12 |
| 体型 | 肥満 |
この研究の注釈：
400mcg chromium given to overweight children who were also given exercise and diet plans (relative to diet and exercise paired with placebo) over the course of six weeks failed to reduce bodyweight relative to placebo (at the P level of 0.05) but the reduction in fat mass and increase in lean mass was greater with chromium than with placebo.
400mcg chromium given to overweight children who were also given exercise and diet plans (relative to diet and exercise paired with placebo) over the course of six weeks failed to reduce bodyweight relative to placebo (at the P level of 0.05) but the reduction in fat mass and increase in lean mass was greater with chromium than with placebo.
Insulin sensitivity was improved to a statistically significant degree, but no other health variable was beneficially influenced.
